References
  1. Swerdlow, S.H., E. Campo, S. A. Pileri, et al. 2016. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375-2390.
  2. Lachenal, F., F. Berger, H. Ghesquières, et al. 2007. Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients. Medicine (Baltimore) 86(5):282-292.
  3. Xie, C., X. Li, H. Zeng, and W. Qian. 2020. Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma. Exp Hematol Oncol 9(1):30.
  4. Botros, N., L. Cerroni, A. Shawwa, et al. 2015. Cutaneous manifestations of angioimmunoblastic T-cell lymphoma: clinical and pathological characteristics. Am J Dermatopathol 37(4):274–283.
  5. Lunning, M. A., and J. M. Vose. 2017. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood 129(9):1095-1102.
  6. Rodríguez-Cortés, J., and T. Palomero. 2016. The curious origins of angioimmunoblastic T-cell lymphoma. Curr Opin Hematol 23(4):434-443.
  7. de Leval, L., D. S. Rickman, C. Thielen, et al. 2007. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 109(11):4952-4963.
  8. Grogg, K. L., A. D. Attygale, W. R. Macon, E. D. Remstein, P. J. Kurtin, and A. Dogan. 2006. Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol 19(8):1101-1107.
  9. Hopfinger, G., and P. Staber. 2019. Current standard in diagnostic and therapy of peripheral T-cell lymphoma. Dtsch Med Wochenschr 144(20):1400-1404.
  10. Dunleavy, K., H. W. Wilson, and E. S. Jaffe. 2007. Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications. Curr Opin Hematol 14(4):348–353.
  11. Laforga, J. B., J. M. Gasent, and M. Vaquero. 2010. Potential misdiagnosis of angioimmunoblastic T-cell lymphoma with Hodgkin’s lymphoma: a case report. Acta Cytol 54(5):840-844.
  12. Gao, X., W. Huang, W. Li, J. Xie, Y. Zheng, and X. Zhou. 2015. Clinicopathologic analysis of angioimmunoblastic T-cell lymphoma with Hodgkin/Reed-Sternberg-like cells. Chin J Pathol 8(44):553-558.
  13. Parekh, V., and D. Peker. 2015. EBV-related primary splenic lymphocyte-depleted classical Hodgkin lymphoma. J Clin Pathol 68(11):947-950.
  14. Ferrarini, I., A. Rigo, C. Visco, M. Krampera, and F. Vinante. 2020. The evolving knowledge on T and NK cells in classic Hodgkin lymphoma: insights into novel subsets populating the immune microenvironment. Cancers (Basel) 12(12):3757.
  15. Connors, J. M. 2020. Hodgkin lymphoma: outsmarting HRS cells. Blood 136(21):2362-2364.
  16. Moccia, A. A., S. Aeppli, S. Güsewell, et al. 2021. Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland. Hematol Oncol 39(2):196-204.